Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 803 results for "evp of research development"

T.J. Martell Foundation to Honor Dynamic Leaders at 2015 Women of Influence Awards and Brunch
SearchBug

T.J. Martell Foundation to Honor Dynamic Leaders at 2015 Women...

Los Angeles celebration will honor Jennifer Justice, EVP of Strategic Marketing & Business Development, Roc Nation;Ty Stiklorius, Co-President, Atom Factory; Sherry Dewane, Wealth Advisor for Wells Fargo; and Sandra Fluke, California State Director, ... Red Orbit, 1 week ago
[x]  

9 images for evp of research development

WTOC TV, 1 month ago
ADVFN UK, 1 month ago
Shelby Report, 2 weeks ago
PR Newswire, 1 month ago
New Indian Express, 5 months ago
PR inside, 3 months ago
Citybizlist, 4 months ago
KXXV-TV, 4 months ago
Sys-Con Media, 4 months ago

[itvt] Radio Interview: Steve Shannon, EVP and GM of Product Development, Gemstar-TV Guide

In this recorded interview from [itvt]'s new talk radio show, "The TV of Tomorrow Show with Tracy Swedlow," Steve Shannon, EVP and general manager of product management at EPG developer, Gemstar-TV Guide , discusses, among other things, the ...
 Interactive TV Today1 week ago

Vera Bradley: A Top Contrarian Play In Retail

A), Includes: COH, FOSL, KATE, KORS by: Helix Investment Research Subscribers to SA PRO had an early look at this article. Learn more about PRO » Summary With over 33% of the company's float sold short, sentiment surrounding Vera Bradley has ...
 Seeking Alpha1 day ago

Positive preclinical antiviral and safety profile of MIV-802 supports continued development

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announce that the preclinical antiviral and safety profile of MIV-802, Medivir's wholly-owned nucleotide polymerase inhibitor under development for the treatment of hepatitis C virus ...
 NASDAQ OMX3 days ago Medivir: Positive preclinical antiviral and safety profile of MIV-802 supports continued development  Reuters3 days ago Medivir: Data from OPTIMIST trials show SVR12 rates of 97 percent in HCV patients without cirrhosis and 84 percent in HCV patients with cirrhosis  Scottrade3 days ago Data from OPTIMIST trials show SVR12 rates of 97 percent in HCV patients without cirrhosis and 84 percent in HCV patients with cirrhosis  NASDAQ OMX3 days ago
[x]  
Mobihealthnews

AstraZeneca and PatientsLikeMe sign five-year research agreement

AstraZeneca plc and PatientsLikeMe have signed a five-year research agreement, under which AstraZeneca will use patient-reported data from PatientsLikeMe in support of its research initiatives. AstraZeneca will use patient-reported data from ...
 Individual.com5 days ago PatientsLikeMe and AstraZeneca Announce Global Research Collaboration  Fierce Biotech IT1 week ago PatientsLikeMe inks AstraZeneca deal, studies Fitbit use for MS patients with Biogen  Mobihealthnews1 week ago
Citybizlist

Tal Medical raises $14 million funding round from new and existing investors

Tal Medical, a clinical-stage medical device company developing a new treatment for depression and other psychiatric disorders, today announced a $14 million funding round from existing investor PureTech, a new institutional investor, and several ...
 News-Medical.Net5 days ago Tal Medical Secures $14M Financing Round and Adds Industry Veterans to Team  FierceMedicalDevices6 days ago
[x]  

Foundation for Sarcoidosis Research Announces First New York Fundraiser With Support of EnGeneIC

Kick In to Stop Sarcoidosis to Raise Funds for Rare, Potentially Fatal Inflammatory Disease NEW YORK, April 16, 2015 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research announced its "Kick in to Stop Sarcoidosis" ("K.I.S.S.") New York ...
 Fat Pitch Financials1 week ago
[x]  

St. Louis delegation cultivates Israeli agrotech

Business, science, and economic development leaders from St. Louis, Missouri are back in Israel this week to participate in an important industry conference and trade show while meeting with a select group of companies and research institutes. I ...
 The Times Of Israel11 hours ago

Perrigo Company PLC Given Buy Rating at Deutsche Bank (PRGO)

Deutsche Bank reiterated their buy rating on shares of Perrigo Company PLC (NASDAQ:PRGO) in a research note released on Thursday morning. They currently have a $208.00 target price on the stock, up from their previous target price of $205.00. ...
 SleekMoney2 days ago Stifel Nicolaus Lowers Perrigo Company PLC to Hold (PRGO)  SleekMoney5 days ago Perrigo Company PLC Receives $173.20 Consensus PT from Analysts (NASDAQ:PRGO)  SleekMoney12 hours ago Zacks: Karyopharm Therapeutics Receives Average Recommendation of Strong Buy from Analysts (NASDAQ:KPTI)  SleekMoney1 week ago

Gilead Sciences Earns Buy Rating from Morgan Stanley (GILD)

Morgan Stanley reissued their buy rating on shares of Gilead Sciences (NASDAQ:GILD) in a research report released on Friday morning. In other Gilead Sciences news, EVP Norbert W. Bischofberger sold 70,000 shares of Gilead Sciences stock on the ...
 SleekMoney12 hours ago Canaccord Genuity Analysts Give DexCom a $69.00 Price Target (DXCM)  American Banking News1 week ago Cepheid's Buy Rating Reiterated at Cantor Fitzgerald (CPHD)  American Banking News12 hours ago Cepheid Earns Buy Rating from Canaccord Genuity (CPHD)  American Banking News12 hours ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less